AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Oral Cavity Surgery

RecruitingNAAges 18 Years - anyAllENIKAM d.o.o.
💬

In plain words

What the trial is, and whether it could suit you

Oral tissue healing is significantly affected by the high bacterial load and constant mechanical stress within the oral cavity. To control bacterial colonization and support healing, both topical and systemic treatments-such as antibiotics and anti-inflammatory agents-are commonly recommended. In addition to pharmacological therapies, mouthwashes containing peroxide, hyaluronic acid, chitosan, or chlorhexidine are often used to maintain low levels of pathogenic bacteria. However, current recommendations for mouthwash use are primarily based on their antibacterial properties in a healthy oral environment. Evidence supporting their role in promoting wound healing, particularly after oral surgery, remains limited. OROXID® mouthwash is a medical device formulated with active oxygen (peroxide compounds). It supports the prevention and relief of inflammation in gingival and paranasal tissues

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Systemically healthy individuals aged 18 years or older. 2. Indicated for surgical removal of an erupted or unerupted tooth and/or apicoectomy. 3. Ability and willingness to comply with post-operative oral hygiene instructions. 4. Signed informed consent form prior to participation in the study. Exclusion Criteria: 1. Receipt of periodontal treatment within the past 3 months. 2. Use of mouthwashes or oral gels in the past month. 3. Presence of active gingivitis around the tooth scheduled for extraction. 4. Known allergy to any ingredients of the investigational products. 5. Presence of inflammatory conditions in the oral cavity, such as lichen planus, bullous lesions, or active gingivitis. 6. Immunocompromised individuals. 7. Known allergy to penicillin or diclofenac. 8. Pregnant or breastfeeding women. 9. Smokers who consume more than 15 cigarettes per day.
💊

What it tests

  • OROXID® forte oral solution
  • Standard of Care (SOC)
📍

Where

1 site
Klinika Križaj
Muljava, Slovenia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy